The largest database of trusted experimental protocols

Mts reagent

Manufactured by Merck Group
Sourced in United States

The MTS reagent is a laboratory product manufactured by Merck Group. It is a colorimetric assay used for the quantitative determination of cell viability and proliferation. The reagent contains a tetrazolium compound that is reduced by metabolically active cells, producing a colored formazan product that can be measured spectrophotometrically.

Automatically generated - may contain errors

17 protocols using mts reagent

1

Evaluating EGCG and Cisplatin Effects on HeLa Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cell viability was determined by MTS Assays. HeLa cells were seeded 3000 cells in a 96-well plate and incubated overnight. Cells (2–5 × 104) were treated with EGCG (25 μM), cisplatin (250 nM), and their combination treatment for 24 h. After 24 h of total treatment, the cells were incubated at 37°C with 1 mg/mL MTS reagent (Sigma, St. Louis, MO, USA) for 2 h. The formazan crystals were dissolved in isopropanol. Spectrophotometric absorbance of the samples was determined by the ULTRA Multifunctional Microplate Reader (ELx800-BIO-TEK) at 490 nm. MTS assay repeated at least three times.
+ Open protocol
+ Expand
2

Colorimetric Assay for Cell Viability

Check if the same lab product or an alternative is used in the 5 most similar protocols
A 3- (4,5-dimethylthiazol-2-yl) -5- (3-carboxymethoxyphenyl) -2- (4-sulfophenyl) -2H-tetrazolium (MTS) colorimetric assay was used to determine the viability of cells. In brief, cells were seeded in 96-well plates at a concentration of 104 cells per well and incubated overnight to allow cells to attach. After incubation, the cells were treated with lycopene alone (10 µM), cisplatin alone (1 µM), and in combination for 72 h. The cells were incubated at 37 °C in 5% CO2 for 2 h after 72 h of total treatment. For assay a 1 mg/mL MTS reagent (Sigma, St. Louis, MO, USA) was added to each well. The absorbance of the solution was estimated using a microplate reader (BioTek Instruments, Winooski, VT, USA) at 490 nm. The sample readings were calculated by subtracting the mean of background absorbances. Viability was calculated concerning control cells (%). MTS assay was performed at least four times.
+ Open protocol
+ Expand
3

Colorimetric MTS Assay for Cell Proliferation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cell proliferation was measured using the colorimetric MST assay using methanethiosulfonate (MTS) reagent (Sigma Aldrich, St Louis, MO, USA). Briefly, the cells were collected and seeded into 96-well plates in triplicate at 800 cells/well. After 24 h, 20 μL of MTS (5 mg/mL) was added to quantify cell proliferation on seven consecutive days. The cells were incubated with MTS for 3 h and then the optical absorbance of each well was measured at 490 nm using a microplate reader. Cell growth curves were created by plotting the absorbance (ordinate) against time (abscissa).
+ Open protocol
+ Expand
4

Cell Proliferation and Drug Sensitivity Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cell proliferation was measured by BrdU assay (Millipore, USA). For cell cycle analysis, after fixation in 70% ethanol, cells were incubated in PI/RNase (BD Biosciences, USA), and analyzed using an Accuri C6 flow cytometer and ModFit LT software (BD Biosciences, USA). For drug sensitivity assay, cells were treated with 0.4 mg/ml 5-FU, 0.004 mg/ml DDP and 0.0004 mg/ml ADM (sigma, USA) for 48 hours. MTS reagent (Sigma, USA) was added to each well following the manufacturer’s instructions to determine drug sensitivity.
+ Open protocol
+ Expand
5

MTS Assay for Microglial Viability

Check if the same lab product or an alternative is used in the 5 most similar protocols
The MTS (3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H–tetrazolium) assay was used to quantify metabolic activity as a second parameter of cell viability [37 ]. Microglia were grown in 96-well plates as described above. Following CNT treatment, microglia were washed with complete medium and incubated with fresh complete medium (100 µL) containing 10 µL MTS reagent (Sigma, UK). Microglia were incubated at 37°C for 1–2 hrs and the optical density measured at 450 nm to determine intracellular NADH levels. Viability was determined from the optical density as a percentage of control cells. Similarly to LDH assays, the adenylyl cyclase inhibitor, MDL-12330, was employed as a positive control for cell death.
+ Open protocol
+ Expand
6

Signaling Pathway Analysis of Myogenesis

Check if the same lab product or an alternative is used in the 5 most similar protocols
MTS reagent, SB202190, and compound C were purchased from Sigma-Aldrich (St Louis, MO, USA). Antibodies against myosin heavy chain (MHC), Akt, p38 MAPK, and myogenin were obtained from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Antibodies against phospho-Akt, phospho-p38 MAPK, and phosphor-AMPK were obtained from Cell Signaling (Beverly, MA, USA). PGC-1α antibody was purchased from Abcam (Cambridge, MA, USA).
+ Open protocol
+ Expand
7

Cell Proliferation Assay with EPZ005687 and UNC1999

Check if the same lab product or an alternative is used in the 5 most similar protocols
Viable cell densities were determined by using the CellTiter 96 One Solution Cell Proliferation Assay (Promega, Madison, WI, USA) according to the manufacturer’s instructions. Briefly, cells were plated at a density of 10, 000/well in 96-well plates and incubated for 24–96 h with increasing concentrations of EPZ005687 or UNC1999. The cells were then incubated with MTS reagent (Sigma, M2128) for 3 h, and analyzed with 490 nm absorbance using microplate reader (Bio-Rad, Laboratories, USA). The data analysis was performed by GraphPad Prism (version 5.01, GraphPad Software, USA). The studies were independently conducted in at least three separate times and each experiment had six replicate wells on one plate.
+ Open protocol
+ Expand
8

Bicalutamide's Effect on Cell Viability

Check if the same lab product or an alternative is used in the 5 most similar protocols
LetR cells were steroid-depleted for 72 hours and then seeded into a 24-well plate prior to the addition of bicalutamide (Bica) (1 μM) (Sigma Aldrich) or vehicle (dimethyl sulfoxide DMSO; 0.01 %) to regular growth medium. MTS reagent (Sigma Aldrich) was added after 2, 3 and 4 days respectively and the resultant colorimetric outputs analyzed by measuring the absorbance at 490nm using a spectrophotometer (Perkin Elmer).
+ Open protocol
+ Expand
9

Cell Proliferation Evaluation using MTS Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
A density of 800 transfected cells per well were plated and cultured in 96-well plates. Cell proliferation was evaluated for 7 consecutive days using the methanethiosulfonate (MTS) assay. In brief, 20 μL MTS reagent (5 mg/mL, Sigma-Aldrich, Shanghai, China) was added to the plated cells and the optical density (OD) was recorded at 490 nm by a spectrophotometric reader (EPOCH2, Bio-Tek, Winooski, USA) after 3 hrs’ incubation. All experiments were repeated in triplicate.
+ Open protocol
+ Expand
10

Cell Viability Assay Using Sunitinib

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were seeded onto 96-well plates at a density of 4 × 103 cells per well in media with 10% FBS and allowed to attach for 24 h. DMSO or sunitinib was added at different concentrations. After 24 h of treatment, MTS reagent (Sigma-aldrich St Louis, MO) was added to cells (1:10 ratio) in each well and allowed to incubate at 37°C in a humid atmosphere with 5% CO2 for 2hrs. After that, plate was read at 490 nm using an Epoch spectrophotometer (BioTek Winooski, VT). All experiments were performed in triplicate and repeated a minimum of three times. Percent viability and cytotoxicity as well as standard deviations and IC50 were calculated from the absorbance values using Microsoft Excel.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!